Neurosciences News

WAIKOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2022, Andrew G. Lee, MD, discusses ways to differentiate between glaucoma and nonglaucomatous neuro-ophthalmic disease.

AUSTIN, Texas — In this Healio Video Perspective from the North American Neuro-Ophthalmology Society meeting, Nailyn Rasool, MD, discusses orbital inflammatory syndromes and offers an overview for treatment.

AUSTIN, Texas — In this Healio Video Perspective from the North American Neuro-Ophthalmology Society meeting, Prem Subramanian, MD, PhD, discusses the sustained efficacy of teprotumumab in patients with thyroid eye disease.

WAIKOLOA, Hawaii — At Hawaiian Eye 2022, Andrew G. Lee, MD, discusses key concepts in diagnosing relative afferent pupillary defects.

WAIKOLOA, Hawaii — Andrew G. Lee, MD, showed multiple ways to detect relative afferent pupillary defects in the practice during a panel discussion at Hawaiian Eye 2022.

An 88-year-old woman developed an acute onset of painless, monocular vision loss in the right eye.

Few randomized clinical trials support using repository corticotropin injection for most FDA-approved indications, including rheumatoid arthritis, ankylosing spondylitis, lupus, optic neuritis and nephrotic syndrome, according to researchers.

When I see patients experiencing problems with a premium presbyopia-correcting IOL, I first and foremost always wait because I need to figure out the root cause as to why they are unhappy.

An 11-year-old boy presented to the University of New Mexico Hospital with 6 weeks of vomiting and food intolerance as well as a 13-pound weight loss over that same period.

Chugai Pharmaceutical Co. released data showing Enspryng had a favorable benefit-risk profile and effectively reduced relapses over 4 years of treatment among people with a form of neuromyelitis optica spectrum disorder.